Tag: nanoparticles
FDA Accepts Investigational New Drug Application for Novel Peanut Allergy Therapy
The company, which is already in phase 2 clinical trials with a treatment for celiac disease, has announced the FDA has accepted their Investigational New Drug (IND) application for evaluation of CNP-201, A treatment for peanut allergy. that reduces the need for strict peanut avoidance and reduces the potentially fatal health risks associated with peanut allergy.
Nanoparticle Shows Promise for Treatment of Severe Allergies
UCLA scientists develop approach that enables immune system to tolerate allergens.
New Treatment May Reverse Celiac Disease
New technology may be applicable to other autoimmune diseases and allergies.
Researchers Develop First Functional Targeted Inhibitors of Peanut Allergens
“The success of this study is exciting because it opens the door to establishing an entirely new class of allergy therapeutics."
Study: Researchers Retrained Immune Systems of Mice to Switch Off Anaphylaxis
"This study in mice proves the concept of this approach, so tests in humans are not that far off."
New Diagnostic Tool Determines Severity of Peanut Allergies Without Exposure to...
Exciting news that may fundamentally change the way allergists test for the presence and severity of food allergies.
